• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性呼吸道疾病相关肺动脉高压的临床特征及危险因素:一项回顾性研究

Clinical characteristics and risk factors of pulmonary hypertension associated with chronic respiratory diseases: a retrospective study.

作者信息

Chen Yonghua, Liu Chunli, Lu Wenju, Li Mengxi, Hadadi Cyrus, Wang Elizabeth Wenqian, Yang Kai, Lai Ning, Huang Junyi, Li Shiyue, Zhong Nanshan, Zhang Nuofu, Wang Jian

机构信息

1 State Key Laboratory of Respiratory Diseases, Guangzhou Institute of Respiratory Disease, The Affiliated Hospital of Guangzhou Medical University, Guangdong 510120, China ; 2 Geisinger Medical Center, 100 North Academy Avenue, Danville, USA ; 3 Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, USA.

出版信息

J Thorac Dis. 2016 Mar;8(3):350-8. doi: 10.21037/jtd.2016.02.58.

DOI:10.21037/jtd.2016.02.58
PMID:27076929
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4805801/
Abstract

BACKGROUND

Chronic respiratory disease-associated pulmonary hypertension (PH) is an important subtype of PH, which lacks clinical epidemiological data in China.

METHODS

Six hundred and ninety three patients hospitalized from 2010 to 2013 were classified by echocardiography according to pulmonary arterial systolic pressure (PASP): mild (36≤ PASP <50 mmHg); moderate (50≤ PASP <70 mmHg) and severe (PASP ≥70 mmHg).

RESULTS

Dyspnea (93.51%) was the most common symptom. Hemoptysis observed in the severe group (6.42%) was significantly higher than the other two groups (P<0.05). COPD (78.35%), lung bullae (44.16%), tuberculosis (including obsolete pulmonary tuberculosis) (38.82%), and bronchiectasis (30.45%) were frequently present. Mild group occupied the highest proportion (84.7%) in COPD, while severe group occupied the highest proportion (19.3%) in pulmonary embolism (P<0.01). Age, partial pressure of oxygen (PaO2), hematocrit (HCT), partial pressure of carbon dioxide (PaCO2), increase of N-terminal pro brain natriuretic peptide (NT-proBNP) and right ventricular (RV) diameter (>20 mm) were associated with moderate-to-severe PH, while RV [odds ratio (OR) =3.53, 95% CI, 2.17-5.74], NT-proBNP (OR=2.44, 95% CI, 1.51-3.95), HCT (OR=1.03, 95% CI, 1.00-1.07) and PaCO2 (OR=1.01, 95% CI, 1.00-1.03) were independent risk factors.

CONCLUSIONS

PH related to respiratory diseases is mostly mild to moderate, and the severity is associated with the category of respiratory disease. Increased HCT can be an independent risk factor for PH related to chronic respiratory diseases.

摘要

背景

慢性呼吸道疾病相关肺动脉高压(PH)是PH的一种重要亚型,中国缺乏其临床流行病学数据。

方法

对2010年至2013年住院的693例患者,根据肺动脉收缩压(PASP)通过超声心动图进行分类:轻度(36≤PASP<50mmHg);中度(50≤PASP<70mmHg)和重度(PASP≥70mmHg)。

结果

呼吸困难(93.51%)是最常见症状。重度组咯血发生率(6.42%)显著高于其他两组(P<0.05)。慢性阻塞性肺疾病(COPD)(78.35%)、肺大疱(44.16%)、肺结核(包括陈旧性肺结核)(38.82%)和支气管扩张(30.45%)较为常见。轻度组在COPD中占比最高(84.7%),而重度组在肺栓塞中占比最高(19.3%)(P<0.01)。年龄、氧分压(PaO2)、血细胞比容(HCT)、二氧化碳分压(PaCO2)、N末端脑钠肽前体(NT-proBNP)升高及右心室(RV)直径(>20mm)与中重度PH相关,而RV[比值比(OR)=3.53,95%可信区间(CI),2.17 - 5.74]、NT-proBNP(OR = 2.44,95%CI,1.51 - 3.95)、HCT(OR = 1.03,95%CI,1.00 - 1.07)和PaCO2(OR = 1.01,95%CI,1.00 - 1.03)是独立危险因素。

结论

与呼吸道疾病相关的PH大多为轻度至中度,其严重程度与呼吸道疾病类型有关。HCT升高可能是慢性呼吸道疾病相关PH的独立危险因素。

相似文献

1
Clinical characteristics and risk factors of pulmonary hypertension associated with chronic respiratory diseases: a retrospective study.慢性呼吸道疾病相关肺动脉高压的临床特征及危险因素:一项回顾性研究
J Thorac Dis. 2016 Mar;8(3):350-8. doi: 10.21037/jtd.2016.02.58.
2
[Natriuretic peptides as markers of development and prognosis of pulmonary hypertension severity in patients with chronic obstructive disease.].[利钠肽作为慢性阻塞性疾病患者肺动脉高压严重程度的发展及预后标志物。]
Klin Lab Diagn. 2018;63(6):333-337. doi: 10.18821/0869-2084-2018-63-6-333-337.
3
[Assessment of the hemodynamics of pulmonary artery and right ventricular function in chronic obstructive pulmonary disease with pulmonary hypertension using cardiac magnetic resonance imaging].[利用心脏磁共振成像评估慢性阻塞性肺疾病合并肺动脉高压患者的肺动脉血流动力学及右心室功能]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Aug;31(8):972-977. doi: 10.3760/cma.j.issn.2095-4352.2019.08.012.
4
[Pulmonary arterial hypertension as leading manifestation of methylmalonic aciduria: clinical characteristics and gene testing in 15 cases].[以甲基丙二酸尿症为主要表现的肺动脉高压:15例临床特征及基因检测]
Beijing Da Xue Xue Bao Yi Xue Ban. 2017 Oct 18;49(5):768-777.
5
Treatment of acute exacerbations with non-invasive ventilation in chronic hypercapnic COPD patients with pulmonary hypertension.无创通气治疗伴有肺动脉高压的慢性高碳酸血症 COPD 急性加重期患者。
Eur Rev Med Pharmacol Sci. 2012 Feb;16(2):183-91.
6
Echocardiographic estimation of pulmonary arterial systolic pressure in acute heart failure. Prognostic implications.超声心动图估测急性心力衰竭患者肺动脉收缩压及其预后意义。
Eur J Intern Med. 2013 Sep;24(6):562-7. doi: 10.1016/j.ejim.2013.04.009. Epub 2013 May 15.
7
Pulmonary Hypertension in Patients With Severe Aortic Stenosis: Prognostic Impact After Transcatheter Aortic Valve Replacement: Pulmonary Hypertension in Patients Undergoing TAVR.严重主动脉瓣狭窄患者的肺动脉高压:经导管主动脉瓣置换术后的预后影响:行经导管主动脉瓣置换术的患者的肺动脉高压。
JACC Cardiovasc Imaging. 2019 Apr;12(4):591-601. doi: 10.1016/j.jcmg.2018.02.015. Epub 2018 Apr 18.
8
Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.血清N末端脑钠肽作为肺动脉高压患者的预后参数。
Chest. 2006 May;129(5):1313-21. doi: 10.1378/chest.129.5.1313.
9
Choice of marker for assessment of RV dysfunction in acute pulmonary embolism : NT-proBNP, pulmonary artery systolic pressure, mean arterial pressure, or blood pressure index.急性肺栓塞中右心室功能障碍评估标志物的选择:N末端脑钠肽前体、肺动脉收缩压、平均动脉压还是血压指数。
Herz. 2017 Dec;42(8):758-765. doi: 10.1007/s00059-016-4513-6. Epub 2016 Dec 13.
10
Relationship between severity of pulmonary hypertension and coronary sinus diameter.肺动脉高压严重程度与冠状窦直径之间的关系。
Rev Port Cardiol. 2015 May;34(5):329-35. doi: 10.1016/j.repc.2014.11.017. Epub 2015 May 7.

引用本文的文献

1
Perspectives from the 2 International Post-Tuberculosis Symposium: mobilising advocacy and research for improved outcomes.第二届国际结核病后研讨会的观点:动员宣传与研究以改善结局
IJTLD Open. 2024 Mar 1;1(3):111-123. doi: 10.5588/ijtldopen.23.0619. eCollection 2024 Mar.
2
Pulmonary hypertension in adults completing tuberculosis treatment.完成结核病治疗的成人中的肺动脉高压
Afr J Thorac Crit Care Med. 2023 Sep 19;29(3). doi: 10.7196/AJTCCM.2023.v29i3.676. eCollection 2023.
3
Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative - Group 3 Pulmonary Hypertension.与间质性肺疾病相关的肺动脉高压的发病机制、临床特征及表型:肺血管研究所创新药物开发计划 - 3组肺动脉高压共识声明
Pulm Circ. 2023 Apr 1;13(2):e12213. doi: 10.1002/pul2.12213. eCollection 2023 Apr.
4
The prevalence of pulmonary hypertension after successful tuberculosis treatment in a community sample of adult patients.成年患者社区样本中成功治疗结核病后肺动脉高压的患病率。
Pulm Circ. 2023 Jan 1;13(1):e12184. doi: 10.1002/pul2.12184. eCollection 2023 Jan.
5
Development of an Electronic Frailty Index for Predicting Mortality and Complications Analysis in Pulmonary Hypertension Using Random Survival Forest Model.使用随机生存森林模型开发用于预测肺动脉高压死亡率和并发症分析的电子衰弱指数
Front Cardiovasc Med. 2022 Jul 8;9:735906. doi: 10.3389/fcvm.2022.735906. eCollection 2022.
6
Associations of Clinical Characteristics and Intestinal Flora Imbalance in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients and the Construction of an Early Warning Model.稳定期慢性阻塞性肺疾病(COPD)患者临床特征与肠道菌群失衡的相关性及预警模型的构建。
Int J Chron Obstruct Pulmon Dis. 2021 Dec 18;16:3417-3428. doi: 10.2147/COPD.S330976. eCollection 2021.
7
Statins for the Treatment of Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease.他汀类药物用于治疗慢性阻塞性肺疾病患者的肺动脉高压
Front Pharmacol. 2021 Jan 8;11:613761. doi: 10.3389/fphar.2020.613761. eCollection 2020.
8
Characteristics of Chronic Obstructive Pulmonary Disease Patients with Pulmonary Hypertension Assessed by Echocardiography in a Three-Year Observational Cohort Study.超声心动图评估的三年观察性队列研究中慢性阻塞性肺疾病合并肺动脉高压患者的特征。
Int J Chron Obstruct Pulmon Dis. 2020 Mar 3;15:487-499. doi: 10.2147/COPD.S230952. eCollection 2020.
9
Renal cell carcinoma: predicting RUNX3 methylation level and its consequences on survival with CT features.肾细胞癌:利用 CT 特征预测 RUNX3 甲基化水平及其对生存的影响。
Eur Radiol. 2019 Oct;29(10):5415-5422. doi: 10.1007/s00330-019-06049-3. Epub 2019 Mar 15.

本文引用的文献

1
Pulmonary arterial hypertension.肺动脉高压
Orphanet J Rare Dis. 2013 Jul 6;8:97. doi: 10.1186/1750-1172-8-97.
2
Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).肺动脉高压诊断和治疗指南:欧洲心脏病学会(ESC)和欧洲呼吸学会(ERS)肺动脉高压诊断和治疗工作组,得到国际心肺移植学会(ISHLT)认可。
Eur Heart J. 2009 Oct;30(20):2493-537. doi: 10.1093/eurheartj/ehp297. Epub 2009 Aug 27.
3
ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association.美国心脏病学会基金会专家共识文件工作组与美国心脏协会合作制定的2009年ACCF/AHA肺动脉高压专家共识文件,与美国胸科医师学会、美国胸科学会以及肺动脉高压协会共同完成。
J Am Coll Cardiol. 2009 Apr 28;53(17):1573-619. doi: 10.1016/j.jacc.2009.01.004.
4
Pulmonary hypertension in COPD.慢性阻塞性肺疾病中的肺动脉高压
Eur Respir J. 2008 Nov;32(5):1371-85. doi: 10.1183/09031936.00015608.
5
Epidemiology of pulmonary hypertension: new data from the Swiss registry.肺动脉高压的流行病学:来自瑞士注册机构的新数据。
Swiss Med Wkly. 2008 Jun 28;138(25-26):379-84. doi: 10.4414/smw.2008.11915.
6
Pulmonary hypertension in Switzerland: treatment and clinical course.瑞士的肺动脉高压:治疗与临床病程
Swiss Med Wkly. 2008 Jun 28;138(25-26):371-8. doi: 10.4414/smw.2008.11914.
7
Registry and survival study in chinese patients with idiopathic and familial pulmonary arterial hypertension.中国特发性和家族性肺动脉高压患者的登记与生存研究
Chest. 2007 Aug;132(2):373-9. doi: 10.1378/chest.06-2913. Epub 2007 Mar 30.
8
Pulmonary arterial hypertension in France: results from a national registry.法国肺动脉高压:一项全国性登记研究的结果
Am J Respir Crit Care Med. 2006 May 1;173(9):1023-30. doi: 10.1164/rccm.200510-1668OC. Epub 2006 Feb 2.
9
Pulmonary hypertension: echocardiographic assessment.肺动脉高压:超声心动图评估
Ital Heart J. 2005 Oct;6(10):840-5.
10
The significance of elevated brain natriuretic peptide levels in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中脑钠肽水平升高的意义
J Int Med Res. 2005 Sep-Oct;33(5):537-44. doi: 10.1177/147323000503300509.